Tackling cancer in China

Classification of thymic tumours

Significance of the ALK Marker in non-smoker lung cancer patients

Treatment options for low grade neuroendocrine lung carcinoma

Role of predictive markers in personalised cancer treatment

Oncotype DX testing to determine adjuvant therapy for breast cancer patients

The European Academy of Cancer Sciences

Prostate screening and the Forum Against Cancer Europe

Oncotype DX gene assay test

Update of the NSABP STAR trial: preventing breast cancer

Determinants of outcome in breast cancer patients

Genetic susceptibility to cancer